Peiyao Jia
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 27
-
- Antibiotic Use and Resistance 7
- Endocrinology top 5%
- Enterobacteriaceae and Cronobacter Research 3
- Pollution top 10%
- Pharmaceutical and Antibiotic Environmental Impacts 6
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing 8
-
- Antibiotics Pharmacokinetics and Efficacy 11
-
- Tuberculosis Research and Epidemiology 3
-
- Bacteriophages and microbial interactions 3
- Journals
- SHILAP Revista de lepidopterología (3 papers)Oncogene (1 paper)Frontiers in Microbiology (7 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Peiyao Jia
37 papers receiving 681 citations
Peers
Comparison fields: 5 of 79
- Molecular Medicine 459
- Applied Microbiology and Biotechnology 80
- Endocrinology 145
- Pollution 139
- Clinical Biochemistry 71
Countries citing papers authored by Peiyao Jia
This map shows the geographic impact of Peiyao Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peiyao Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peiyao Jia more than expected).
Fields of papers citing papers by Peiyao Jia
This network shows the impact of papers produced by Peiyao Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peiyao Jia. The network helps show where Peiyao Jia may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peiyao Jia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 9 | |
| 4 | 2024 | 11 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 8 | |
| 8 | 2023 | 6 | |
| 9 | 2022 | 13 | |
| 10 | 2021 | 4 | |
| 11 | 2021 | 30 | |
| 12 | 2021 | 17 | |
| 13 | 2021 | 2 | |
| 14 | 2021 | 13 | |
| 15 | 2020 | 202 | |
| 16 | 2020 | 23 | |
| 17 | 2020 | 10 | |
| 18 | 2020 | 9 | |
| 19 | 2020 | 16 | |
| 20 | 2011 | 81 |
About Peiyao Jia
Peiyao Jia is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Clinical Biochemistry, having authored 40 papers that have together received 692 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (27 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers), Bacterial Identification and Susceptibility Testing (8 papers), Antibiotic Use and Resistance (7 papers), Pharmaceutical and Antibiotic Environmental Impacts (6 papers), Tuberculosis Research and Epidemiology (3 papers), Bacteriophages and microbial interactions (3 papers) and Enterobacteriaceae and Cronobacter Research (3 papers). The work is most often cited by research in Molecular Medicine (459 citations), Applied Microbiology and Biotechnology (80 citations) and Endocrinology (145 citations). Peiyao Jia has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Yingchun Xu, Qiwen Yang, Ying Zhu, Yanfeng Xue, Shihe Shao, Jingjia Zhang, Qiwen Yang, Minggui Wang, Zhiyong Zong and Jianzhong Shen. Their work appears in journals such as SHILAP Revista de lepidopterología, Oncogene and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.